Boston-based telehealth company Amwell Health announced it received notice from the New York Stock Exchange (NYSE) that it has fallen out of compliance with NYSE’s minimum stock price requirement.
The listing criteria requires a company’s stock price to be over $1 for 30 consecutive days. Amwell was trading at $0.74 per share at the time this article was published. The company's stock last...
Blackbird, a neuroscience-backed hybrid mental health provider for children and young adults, raised $17 million in February in a Series A funding round led by Define Ventures with participation from Frist Cressey Ventures and GreyMatter, bringing its total raise to $23 million.
The company's CEO, Tom Peterson, sat down with MobiHealthNews to discuss why he went from initially being an investor...
South Korean medical AI company Lunit has recently secured deals with hospitals in Europe, where the medical device market – the second largest after the North American market – is worth $155 billion.
It won the contract to supply a lung disease screening solution to TeleDiag, the largest teleradiology group in France.
Lunit was also chosen to provide a mammography analysis solution to the...
California-based Biolinq, a health technology company developing precision multi-analyte wearable biosensors for metabolic health, announced it scored $58 million in financing.
Alpha Wave Ventures led the round, with participation from Niterra’s corporate venture capital fund, which is jointly operated with Pegasus Tech Ventures.
Existing investors, including AXA IM Alts, Senvest Management,...
Chicago-based GE HealthCare announced it closed its acquisition of AI and imaging solutions company MIM Software, expanding its digital imaging offerings.
Cleveland-based MIM Software provides remote software solutions for oncology, nuclear medicine, cardiac imaging and neuroimaging.
The company touts its products as reducing time spent on manual tasks, allowing clinicians to focus on providing...
DarioHealth, a digital chronic-condition-management platform, reported $3.6 million in revenue for Q4 2023, compared to $6.8 million for the fourth quarter of 2022, a 47% decrease. Year-over-year revenue in 2023 was $20.4 million, compared to $27.7 million for 2022.
The New York-based company said the overall decrease in revenue stemmed from lower consumer and strategic-partner channels.
The...
Telemental health company Brightside Health announced it raised $33 million dollars in Series C funding powered by healthcare-focused venture capital firm S32.
Kennedy Lewis, Time BioVentures, and 23andMe founder Anne Wojcicki participated in the round. Existing investors ACME, Mousse Partners and TriVentures also contributed.
The company confirmed the $33 million raise in an email to...
Digital substance use management platform Pelago, formerly Quit Genius, announced it secured $58 million in Series C funding, bringing its total raise to $151 million.
Existing investor Atomico led the round, with participation from other continuing investors, including Octopus Ventures, Y Combinator and Kinnevik AB. New investors GreyMatter Capital and Eight Roads also participated.
Laura...
Funding worth A$6.5 million ($4 million) has been awarded to four genomics-focused research projects led by researchers from the University of Melbourne.
These include a project that will establish a patient dataset of inherited retinal diseases; a rapid multi-omic liquid biopsy blood test using whole genome sequencing; research using next-generation sequencing to develop new solutions to...
Scottish sensor technology startup Novosound secured a patent for its ultrasound instrumentation system, the Slanj digital platform, which is targeted at the medical and wearable-device market.
Novosound produces a wearable, WiFi-enabled ultrasound device that uses gel-free, high-resolution sensors to solve issues associated with traditional ultrasound technology.
The patent gives Novosound...
